Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis

Digestive Diseases and Sciences

Volumn 44, Issue 2, 1999, Pages 415-423

  Brimnes, Jens ^a   Nielsen, Ole H ^a   Wiik, Allan ^a   Heegaard, Niels H H ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Anti neutrophil cytoplasmic antibodies; Autoantigens; Neutrophils; Ulcerative colitis

Indexed keywords

AUTOANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0032914819     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026683224057     Document Type: Article

References (35)

1. 1. Faber V, Elling P: An antinuclear factor specific for leucocytes. Lancet:344-345, 1964
2. 2. Wiik A: Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy 35:263-289, 1980
3. 3. Davies DJ, Moran JE, Niall JF: Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology? Br Med J 285:606, 1982
4. 4. Wiik A, van der Woude FJ: The new ACPA/ANCA nomenclature. Neth J Med 36:107-108, 1990
5. 5. Lüdemann J, Utecht B, Gross WL: Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171:357-362, 1990
6. 6. Niles JL, McCluskey RT, Ahmad MF, Arnaout AM: Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74:1888-1893, 1989
7. 7. Hagen EC, Bailleux BEPB, van Es LA, Daha MR, van der Woude FJ: Antineutrophil cytoplasmic autoantibodies: A review of the antigens involved, the assays, and the clinical and possible pathogenic consequenses. Blood 81:1996-2002, 1993
8. 8. Gross WL, Csernok E: Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 7:11-19, 1995
9. 9. Banst DS, Flemming KA, Chapmann RW: Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulceralivc colitis: Prevalence, titre, and IgG subclass. Gut 38:384-389, 1996
10. 10. Nielsen H, Wiik A, Elmgreen J: Granulocyte-specific antinuclear antibodies in ulcerative colitis. APMIS 91:23-26, 1983
11. 11. Ellerbroeck PM, Oudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BME, von dem Borne AEGK, Meuwissen SGM: Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol 47:257-262, 1994
12. 12. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F: Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100:1385-1391, 1991
13. 13. Halbwachs-Mecarelli L, Nusbaum P, Noel LH, Reumaux D, Erlinger S, Grunfeld JP, Lesavre P: Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 90:79-84, 1992
14. 14. Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM: Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: Characterization and clinical correlates. Clin Exp Immunol 95:490-497, 1994
15. 15. Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202-210, 1990
16. 16. Broekroelofs J, Mulder AHL, Nelis GF, Westerveld BD, Cohen Tervaert JW, Kallenberg CGM: Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Dig Dis Sci 39(3):545-549, 1994
17. 17. Peen E, Almer S, Bodemar G, Rydén BO, Sjölin C, Tejle K, Skogh T: Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis and Crohn's disease. Gut 34:56-62, 1993
18. 18. Stoffel MP, Csernok E, Herzberg C, Johnston T, Caroll SF, Gross WL: Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): A new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 104:54-59, 1996
19. 19. Peter HH, Metzger D, Rump A, Röther E: ANCA in diseases other than vasculitis. Clin Exp Immunol 93(1):12-14, 1993
20. 20. Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM: Antineutrophil antibodies in inflammatory bowel disease recognize different antigens. In ANCA-Associated Vasculitides: Immunological and Clinical Aspects. WL Gross (ed). New York, Plenum Press, 1993, pp 519-522
21. 21. Sobajima J, Ozaki S, Okazaki T, Osakada F, Sumita S, Mori S, Nakao K: Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: Anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 105:120-124, 1996
22. 22. Sobajima J, Ozaki S, Osakada F, Vesugi H, Shirakawa H, Yoshida M, Nakao K: Novel autoantigens of perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: Non-histone chromosomal proteins HMG1 and HMG2. Clin Exp Immunol 107:166-174, 1997
23. 23. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V: Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 26:1247-1256, 1991
24. 24. Tvede S, Bondesen O, Nielsen OH, Rasmussen SN: Serum antibodies to bacteroides species in chronic inflammatory bowel disease. Scand J Gastroenterol 18:783-789, 1983
25. 25. Wiik A, Rasmussen N, Wieslander J: Methods to detect autoantibodies to neutrophilic granulocytes. In Manual of Biological Markers of Disease. RN Maini, WJ Van Venrooij (eds). Dordrecht, Klüwer Academic Publishers, 1994, pp 1-14
26. 26. LaCour BB, Wiik A, Høier-Madsen M, Rasmussen N, Baslund B: Clinical correlates and substrate specificities of antibodies exhibiting neutrophilocyte nuclear reactivity. J Immunol Methods 187:287-295, 1995
27. 27. Heegaard NHH, Jacobsen DR, Klattschou D: Purification of Wegener's granulomatosis autoantigen, proteinase 3, from neutrophils by Triton X-114 extraction of azurophilic granules. Anal Biochem 253:259-262, 1997
28. 28. Borregaard N, Heiple JM, Simons ER, Clark RA: Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: Translocation during activation. Cell Biol 97:52-61, 1983
29. 29. Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM: Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 17:411-417, 1993
30. 30. Spickett GP, Broomhead V: Formalin fixation and patterns of anti-neutrophil cytoplasmic antibodies. Sarcoidosis, vasculitis and diffuse lung diseases. 13:265, 1996 (abstract)
31. 31. Larsson LI: Fixation and Tissue Pretreatment in Immunocytochemistry: Theory and Practice. Boca Raton, Florida, CRC Press, 1988, pp 41-76
32. 32. Zhao MH, Jones SJ, Lockwood CM: Bactericidal/permeability-increasing protein (BPI) is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 99:49-56, 1995
33. 33. Falk RF, Becker M, Terrell R, Jennette JC: Antigen specificity of p-ANCA and of c-ANCA. Am J Kidney Dis 18:197, 1991 (abstract)
34. 34. Gray PW, Flaggs G, Leong SR, Gumina RJ, Weiss J, Ooi CE, Elsbach P: Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem 264:9505-9509, 1989
35. 35. Pereira HA, Spitznagel JK, Winton EF, Shafer WM, Martin LE, Guzman GS: The ontogeny of a 57-kD cationic antimicrobial protein of human polymorphonuclear leukocytes; localization to a novel granule population. Blood 76:825-834, 1990